Abbott's Trading Volume Plummets 43.95% to $758 Million Ranking 103rd Despite Retail Investor Interest in FreeStyle Libre

Abbott's trading volume on June 25, 2025, was $758 million, a significant decrease of 43.95% from the previous day, ranking 103rd in the day's stock market activity. The stock price of Abbott (ABT) fell by 0.49%.

Abbott and Dexcom have garnered attention from retail investors following comments by Robert F. Kennedy Jr. on social media. Kennedy Jr. highlighted the potential of Abbott's FreeStyle Libre glucose monitoring system and Dexcom's G6 continuous glucose monitor, suggesting that these devices could play a crucial role in managing diabetes and improving patient outcomes. This endorsement has sparked interest among retail investors, who are increasingly looking for innovative healthcare solutions.

Abbott's FreeStyle Libre system has been a standout product, known for its accuracy and convenience. The system allows users to monitor their glucose levels without the need for finger pricks, making it a popular choice among diabetics. The positive sentiment surrounding Abbott's glucose monitoring technology has contributed to the company's visibility in the retail investment community.